SynthesisAnnals of medicine2025
Foetal vitelline vein: a systematic review of the literature.
Synthesis in Annals of medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo summarize and analyse the ultrasound image characteristics and prognosis of persistent vitelline vein.
methodsThe keywords 'vitelline vein' or 'portal vein tumour' were used to search the China Knowledge Network (CNKI), Wipo database, Wanfang database, and Chinese Medical Journal Full Text Database. Pubmed, Embase, and Uptodate databases were searched with the keywords 'vitelline vein' or 'portal vein tumour'. Literature from the above databases up to October 2024 was searched. We summarized the retrieved case data and analysed the pathogenesis, ultrasonographic manifestations, and follow-up prognosis of persistent vitelline veins.
resultsSeventeen relevant English-language publications were retrieved, all in case reports involving 24 patients. Descriptive analysis was used to compare the included cases, and meta-analysis was inappropriate because of the great variation in the quality of the studies.
conclusionPersistent vitelline veins are uncommon, with a low prenatal diagnosis rate of 29.2% of available cases, and are mostly diagnosed postnatally. The diagnosis can be made in the prenatal period by a detailed examination of the portal venous system, which is clinically differentiated most notably from umbilical vein dilatation. Once the diagnosis of persistent vitelline veins is made, and it should be closely followed up in the prenatal period. Patient follow-up should be done by a multidisciplinary team and always in preparation for postpartum surgery to prevent acute severe postpartum complications related to thrombosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.